Can a simple supplement help aging eyes? stanford investigates
NCT ID NCT07269704
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study at Stanford looked at how a nutritional supplement called alpha-ketoglutarate is absorbed into the eyes when taken orally. Seventeen adults with age-related eye diseases participated. The main goal was to measure changes in the supplement's level in eye fluid and to explore related protein changes, not to treat the disease directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EYE DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Byers Eye Institute
Palo Alto, California, 94303, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- 5,000 seniors join landmark eye health study to unlock secrets of aging vision
- New eye scan may spot glaucoma before vision loss begins
- New eye drops aim to replace reading glasses – but are they safe Long-Term?
- Laser before eye implant may prevent glaucoma damage
- Eye camera spots hidden inflammation in MS patients
- New eye injection shows promise for rare Blindness-Causing gene mutation